ORIENTAL RISE HOLDINGS LTD (ORIS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ORIS • KYG6781A1105

1.13 USD
-0.07 (-5.83%)
At close: Feb 6, 2026
1.14 USD
+0.01 (+0.88%)
After Hours: 2/6/2026, 8:00:02 PM
Fundamental Rating

3

ORIS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 88 industry peers in the Food Products industry. While ORIS has a great health rating, there are worries on its profitability. ORIS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ORIS had positive earnings in the past year.
  • In the past year ORIS has reported a negative cash flow from operations.
ORIS Yearly Net Income VS EBIT VS OCF VS FCFORIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2M 4M 6M 8M 10M

1.2 Ratios

  • ORIS has a Return On Assets of 2.98%. This is comparable to the rest of the industry: ORIS outperforms 54.55% of its industry peers.
  • With a Return On Equity value of 3.07%, ORIS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • ORIS has a Return On Invested Capital of 2.49%. This is comparable to the rest of the industry: ORIS outperforms 48.86% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ORIS is significantly below the industry average of 27.77%.
  • The last Return On Invested Capital (2.49%) for ORIS is well below the 3 year average (11.00%), which needs to be investigated, but indicates that ORIS had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.98%
ROE 3.07%
ROIC 2.49%
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ORIS Yearly ROA, ROE, ROICORIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 10.97%, ORIS belongs to the best of the industry, outperforming 88.64% of the companies in the same industry.
  • ORIS's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 11.31%, ORIS is doing good in the industry, outperforming 78.41% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ORIS has declined.
  • ORIS's Gross Margin of 24.17% is in line compared to the rest of the industry. ORIS outperforms 57.95% of its industry peers.
  • ORIS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.31%
PM (TTM) 10.97%
GM 24.17%
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
ORIS Yearly Profit, Operating, Gross MarginsORIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

  • ORIS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ORIS has more shares outstanding than it did 1 year ago.
  • ORIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ORIS Yearly Shares OutstandingORIS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
ORIS Yearly Total Debt VS Total AssetsORIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 13.96 indicates that ORIS is not in any danger for bankruptcy at the moment.
  • ORIS's Altman-Z score of 13.96 is amongst the best of the industry. ORIS outperforms 97.73% of its industry peers.
  • ORIS has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.00, ORIS belongs to the top of the industry, outperforming 88.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.96
ROIC/WACC0.33
WACC7.56%
ORIS Yearly LT Debt VS Equity VS FCFORIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 23.96 indicates that ORIS has no problem at all paying its short term obligations.
  • ORIS's Current ratio of 23.96 is amongst the best of the industry. ORIS outperforms 100.00% of its industry peers.
  • ORIS has a Quick Ratio of 22.06. This indicates that ORIS is financially healthy and has no problem in meeting its short term obligations.
  • ORIS's Quick ratio of 22.06 is amongst the best of the industry. ORIS outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 23.96
Quick Ratio 22.06
ORIS Yearly Current Assets VS Current LiabilitesORIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

  • The earnings per share for ORIS have decreased strongly by -71.90% in the last year.
  • The earnings per share for ORIS have been decreasing by -26.95% on average. This is quite bad
  • ORIS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.10%.
  • ORIS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.44% yearly.
EPS 1Y (TTM)-71.9%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-91.36%
Revenue 1Y (TTM)-37.1%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-35.05%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ORIS Yearly Revenue VS EstimatesORIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.28 indicates a rather cheap valuation of ORIS.
  • 96.59% of the companies in the same industry are more expensive than ORIS, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.93, ORIS is valued rather cheaply.
Industry RankSector Rank
PE 6.28
Fwd PE N/A
ORIS Price Earnings VS Forward Price EarningsORIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.15
ORIS Per share dataORIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ORIS!.
Industry RankSector Rank
Dividend Yield 0%

ORIENTAL RISE HOLDINGS LTD

NASDAQ:ORIS (2/6/2026, 8:00:02 PM)

After market: 1.14 +0.01 (+0.88%)

1.13

-0.07 (-5.83%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.25%
Inst Owner ChangeN/A
Ins Owners2.21%
Ins Owner ChangeN/A
Market Cap41.60M
Revenue(TTM)20.01M
Net Income(TTM)2.20M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.28
Fwd PE N/A
P/S 2.08
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.58
EV/EBITDA -0.15
EPS(TTM)0.18
EY15.93%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.54
BVpS1.94
TBVpS1.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.8
Profitability
Industry RankSector Rank
ROA 2.98%
ROE 3.07%
ROCE 3.16%
ROIC 2.49%
ROICexc 6.01%
ROICexgc 6.01%
OM 11.31%
PM (TTM) 10.97%
GM 24.17%
FCFM N/A
ROA(3y)13.65%
ROA(5y)N/A
ROE(3y)14.57%
ROE(5y)N/A
ROIC(3y)11%
ROIC(5y)N/A
ROICexc(3y)22.86%
ROICexc(5y)N/A
ROICexgc(3y)22.86%
ROICexgc(5y)N/A
ROCE(3y)14.51%
ROCE(5y)N/A
ROICexgc growth 3Y-34.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y-34.59%
ROICexc growth 5YN/A
OM growth 3Y-31.11%
OM growth 5YN/A
PM growth 3Y-30.79%
PM growth 5YN/A
GM growth 3Y-20.11%
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.04
Cap/Depr 21.98%
Cap/Sales 1.28%
Interest Coverage 34.82
Cash Conversion N/A
Profit Quality N/A
Current Ratio 23.96
Quick Ratio 22.06
Altman-Z 13.96
F-Score3
WACC7.56%
ROIC/WACC0.33
Cap/Depr(3y)60.73%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.01%
Cap/Sales(5y)N/A
Profit Quality(3y)117.23%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.9%
EPS 3Y-26.95%
EPS 5YN/A
EPS Q2Q%-91.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.1%
Revenue growth 3Y-12.44%
Revenue growth 5YN/A
Sales Q2Q%-35.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.33%
EBIT growth 3Y-39.69%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.61%
FCF growth 3Y71.83%
FCF growth 5YN/A
OCF growth 1Y-74.39%
OCF growth 3Y-28.66%
OCF growth 5YN/A

ORIENTAL RISE HOLDINGS LTD / ORIS FAQ

What is the fundamental rating for ORIS stock?

ChartMill assigns a fundamental rating of 3 / 10 to ORIS.


What is the valuation status for ORIS stock?

ChartMill assigns a valuation rating of 3 / 10 to ORIENTAL RISE HOLDINGS LTD (ORIS). This can be considered as Overvalued.


How profitable is ORIENTAL RISE HOLDINGS LTD (ORIS) stock?

ORIENTAL RISE HOLDINGS LTD (ORIS) has a profitability rating of 3 / 10.